Blue Zone Wealth Advisors LLC reduced its position in shares of STERIS plc (NYSE:STE – Free Report) by 1.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,533 shares of the medical equipment provider’s stock after selling 404 shares during the quarter. STERIS accounts for 1.9% of Blue Zone Wealth Advisors LLC’s investment portfolio, making the stock its 15th biggest holding. Blue Zone Wealth Advisors LLC’s holdings in STERIS were worth $5,386,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in STERIS by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 11,864,606 shares of the medical equipment provider’s stock worth $2,608,434,000 after acquiring an additional 53,526 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in STERIS by 1.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 5,811,818 shares of the medical equipment provider’s stock valued at $1,277,728,000 after purchasing an additional 77,152 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in STERIS by 7.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,738,630 shares of the medical equipment provider’s stock valued at $390,880,000 after purchasing an additional 120,616 shares in the last quarter. Sustainable Growth Advisers LP increased its stake in STERIS by 23.5% in the 1st quarter. Sustainable Growth Advisers LP now owns 1,485,578 shares of the medical equipment provider’s stock valued at $333,988,000 after buying an additional 282,387 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in STERIS by 3.4% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,009,157 shares of the medical equipment provider’s stock worth $226,879,000 after buying an additional 32,755 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.
Insider Buying and Selling
In other STERIS news, Director Jacqueline B. Kosecoff sold 4,584 shares of the stock in a transaction on Monday, May 13th. The shares were sold at an average price of $231.53, for a total value of $1,061,333.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, VP Renato Tamaro sold 1,154 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the sale, the vice president now directly owns 6,677 shares in the company, valued at $1,546,660.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jacqueline B. Kosecoff sold 4,584 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $231.53, for a total value of $1,061,333.52. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,762 shares of company stock valued at $1,798,477. 1.14% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on STE
STERIS Stock Performance
Shares of NYSE:STE traded down $3.70 during trading on Friday, reaching $235.98. The stock had a trading volume of 427,048 shares, compared to its average volume of 488,756. The stock has a fifty day simple moving average of $225.43 and a two-hundred day simple moving average of $223.04. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49. STERIS plc has a 52 week low of $195.47 and a 52 week high of $243.37. The firm has a market capitalization of $23.33 billion, a price-to-earnings ratio of 61.77 and a beta of 0.83.
STERIS (NYSE:STE – Get Free Report) last announced its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping the consensus estimate of $1.98 by $0.16. STERIS had a net margin of 7.36% and a return on equity of 13.89%. The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the firm posted $2.00 EPS. The business’s quarterly revenue was down .4% on a year-over-year basis. As a group, analysts anticipate that STERIS plc will post 9.16 earnings per share for the current fiscal year.
STERIS Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Thursday, September 5th will be given a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, September 5th. This represents a $2.28 dividend on an annualized basis and a yield of 0.97%. This is a positive change from STERIS’s previous quarterly dividend of $0.52. STERIS’s payout ratio is 59.69%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
See Also
- Five stocks we like better than STERIS
- Energy and Oil Stocks Explained
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- Roth IRA Calculator: Calculate Your Potential Returns
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- Investing In Automotive Stocks
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.